"This coupled with a focus on the injectables space and strong compliance track record are key plus points for Gland. Gland's financial performance over FY18 to FY20 is impressive. The return on equity (RoE) also has improved from 13.3 percent in FY2018 to 21.2 percent in FY20. Looking at the strong domain expertise, a sturdy and consistent earnings track record and healthy return ratios, the future looks good," Sharekhan said. … [Read more...] about Gland Pharma opens for subscription today: Should you subscribe?
The world has been obsessed with owning more and throwing the old away, a direct affront to our oldest Indian values of saving and passing on to the next generation. ‘Restore Love’ was born out of a demand that we course-correct. We, at Antar Agni, wanted to meet this demand made by nature by reviving old, damaged garments and bringing them back to life. Restore Love holds the connotation of cyclic, circuitous change—what better way to describe our bond with clothes. … [Read more...] about How Antar Agni’s new project pays nod to circular fashion, global luxury’s hottest trend in 2020